Use of On-Q Pump for Pain Post C-Section
NCT02579629 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 64
Last updated 2020-10-14
Summary
The main purpose of this study is to examine if pain levels treated with intrathecal (IT) preservative-free morphine (PFM) after a cesarean section improve with the additional use of continuous subfascial wound infiltration with ropivacaine using the OnQ® elastomeric pump system.
Conditions
Interventions
- DRUG
-
Ropivacaine 0.1%
Ropivacaine 0.1% is a local anaesthetic drug and will be administered as a single bolus dose of 8ml of 0.1% ropivacaine followed by an infusion of 8ml/hr of 0.1% ropivacaine using the On-Q® elastomeric pump. The bolus dose of 8ml of 0.1% ropivacaine will be administered via a multiport, silver-impregnated catheter (6-10cm) placed above the rectus muscle parallel to the fascial incision, using a preloaded syringe. The infusion will be delivered by the On-Q® elastomeric pump pre-set to deliver 8ml/hr of 0.1% ropivacaine for 72 hours post-operatively.
- DRUG
-
Ropivacaine 0.2%
Ropivacaine 0.2% is a local anaesthetic drug and will be administered as a single bolus dose of 8ml of 0.2% ropivacaine followed by an infusion of 8ml/hr of 0.2% ropivacaine using the On-Q® elastomeric pump. The bolus dose of 8ml of 0.2% ropivacaine will be administered via a multiport, silver-impregnated catheter (6-10cm) placed above the rectus muscle parallel to the fascial incision, using a preloaded syringe. The infusion will be delivered by the On-Q® elastomeric pump pre-set to deliver 8ml/hr of 0.2% ropivacaine for 72 hours post-operatively.
- DRUG
-
Normal saline
Normal saline will be administered as a single bolus dose of 8ml of normal saline followed by an infusion of normal saline using the On-Q® elastomeric pump. The bolus dose of 8ml of normal saline will be administered via a multiport, silver-impregnated catheter (6-10cm) placed above the rectus muscle parallel to the fascial incision, using a preloaded syringe. The infusion will be delivered by the On-Q® elastomeric pump pre-set to deliver 8ml/hr normal saline for 72 hours post-operatively.
- DEVICE
-
On-Q ® elastomeric pump
The On-Q® elastomeric pump automatically and continuously delivers a regulated flow of 0.1% or 0.2% ropivacaine or normal saline locally to the surgical site for 72 hours post-operatively. The infusion will be delivered by pre-setting the On-Q® elastomeric pump to deliver at the rate of 8ml/hr for 72 hours post-operatively.
Sponsors & Collaborators
-
Emory University
lead OTHER
Principal Investigators
-
James Dolak, MD · Emory University
Study Design
- Allocation
- RANDOMIZED
- Purpose
- SUPPORTIVE_CARE
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2015-07-31
- Primary Completion
- 2019-07-25
- Completion
- 2019-07-25
Countries
- United States
Study Locations
More Related Trials
-
Quadratus Lumborum Block for Post-Cesarean Analgesia
NCT02339766 ·Status: TERMINATED ·Phase: NA
-
Evaluating The Quality of Recovery After Elective Cesarean Section
NCT06155968 ·Status: COMPLETED ·Phase: NA
-
Intrathecal Hydromorphone for Cesarean Section
NCT02067520 ·Status: COMPLETED ·Phase: PHASE4
-
Comparison of 0.1 and 0.05mg Intrathecal Morphine for Post-cesarean Analgesia.
NCT03427463 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Intravenous Versus Oral Acetaminophen for Postoperative Pain Control After Cesarean Delivery
NCT02487303 ·Status: COMPLETED ·Phase: NA
-
Comparison of Different Methods of Pain Control After Cesarean Section for Patients on Buprenorphine or Methadone
NCT02091297 ·Status: WITHDRAWN ·Phase: NA
-
Infiltration Analgesia After Caesarean Section
NCT01094106 ·Status: COMPLETED ·Phase: PHASE4
-
Transcutaneous Electrical Nerve Stimulation for Post-Cesarean Pain Control
NCT04399707 ·Status: RECRUITING ·Phase: NA
-
Spinal Morphine vs. Hydromorphone for Pain Control After Cesarean Delivery
NCT02789410 ·Status: COMPLETED ·Phase: NA
-
Epidural Morphine Versus Epidural Fentanyl Infusion Following Cesarean Section
NCT01362998 ·Status: TERMINATED ·Phase: NA
-
Determining the Optimal Dose of Intrathecal Morphine for Post-Cesarean Analgesia
NCT07023497 ·Status: RECRUITING ·Phase: NA
-
Post-cesarean Analgesia With Epidural Morphine Following Epidural 2-chloroprocaine
NCT04369950 ·Status: COMPLETED ·Phase: PHASE4
-
Analgesic Efficacy of Intrathecal Fentanyl-Morphine Combination Versus Morphine Alone for Intraoperative Pain During Elective Cesarean Delivery
NCT06570343 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Influence of Patient Choice of Intrathecal Morphine on Post-cesarean Delivery Pain.
NCT01425762 ·Status: COMPLETED ·Phase: NA
-
Effect of Bilateral Quadratus Lumborum Block for Pain Relief in Patients With Cesarean Section
NCT03199170 ·Status: COMPLETED ·Phase: NA
-
Transversus Abdominis Plane Block Versus Wound Infiltration for Postcesarean Analgesia
NCT02691572 ·Status: COMPLETED ·Phase: NA
-
ESPB vs Intrathecal Morphine for Assessements of Quality of Recovery After Cesarean Section
NCT07202416 ·Status: RECRUITING ·Phase: NA
-
Impact of a Strategy Combining Morphine Savings and Anesthesia Technique on the Quality of Post-operative Rehabilitation
NCT04377984 ·Status: TERMINATED
-
TENS and Opioid Use After Cesarean Delivery
NCT03843788 ·Status: TERMINATED ·Phase: NA
-
Quadratus Lumborum in Cesarean Section Trial
NCT03673280 ·Status: COMPLETED ·Phase: NA
-
Low Pain Prediction in Cesarean Section Patients
NCT02143141 ·Status: TERMINATED ·Phase: PHASE4
-
Evaluation of the Effect of Postoperative Analgesia Techniques With ObsQoR-10
NCT06978491 ·Status: COMPLETED ·Phase: NA
-
Wound Infusion vs Spinal Morphine for Post-caesarean Analgesia
NCT02264821 ·Status: COMPLETED ·Phase: PHASE3
-
Liposomal Bupivacaine After Cesarean Delivery
NCT03907813 ·Status: WITHDRAWN ·Phase: PHASE4
-
Intrathecal Opioids for Pain Control After Cesarean Delivery: Determining the Optimal Dose
NCT02009722 ·Status: COMPLETED ·Phase: PHASE4